세계의 제형 개발 아웃소싱 시장 보고서(2025년)

Formulation development outsourcing involves the practice of enlisting external experts or organizations to manage the formulation and development process of a product. This outsourcing arrangement enables companies to tap into the specialized knowledge, resources, and expertise of external parties for the development or enhancement of their product formulations.

The primary services offered in formulation development outsourcing include pre-formulation and formulation development. Pre-formulation pertains to the developmental stage in pharmaceutical formulations, encompassing various therapeutic areas such as oncology, infectious disease, neurology, hematology, respiratory, cardiovascular, dermatology, among others. These formulations cover diverse administration methods, including oral, injectable, topical, and others. Formulation development outsourcing is utilized by various end-users, including pharmaceutical industries, research entities, and academic development.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the ensuing trade tensions in spring 2025 are taking a toll on the professional services sector, especially within legal, consulting, architectural, and engineering fields. Increased duties on imported technology, software, office hardware, and digital infrastructure have pushed up operational costs for firms that rely on global systems and resources. Cross-border consulting engagements are experiencing delays and higher expenses due to elevated travel costs and limited access to international data and tools. Moreover, industries heavily impacted by tariffs such as manufacturing, construction, and logistics are reducing their reliance on outsourced services, dampening demand for professional support. In response, service providers are reassessing pricing models, strengthening ties with domestic vendors, and accelerating the adoption of AI and automation to maintain profitability and client satisfaction in an increasingly volatile environment.

The formulation development outsourcing research report is one of a series of new reports from The Business Research Company that provides formulation development outsourcing statistics, including formulation development outsourcing industry global market size, regional shares, competitors with a formulation development outsourcing share, detailed formulation development outsourcing segments, market trends, and opportunities, and any further data you may need to thrive in the formulation development outsourcing industry. This formulation development outsourcing research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The formulation development outsourcing market size has grown strongly in recent years. It will grow from $29.83 billion in 2024 to $32.32 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to cost efficiency, focus on core competencies, regulatory compliance, accelerated drug development, and access to specialized expertise.

The formulation development outsourcing market size is expected to see rapid growth in the next few years. It will grow to $47.68 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to the increased complexity of drug molecules, strategic partnerships, rising R&D costs, biopharmaceutical innovations, and flexible capacity. Major trends in the forecast period include integration of continuous manufacturing processes, outsourcing for modified-release formulations, collaborations for specialized drug delivery systems, regulatory expertise in outsourced services, and utilization of artificial intelligence (AI) in formulation design.

The forecast of 10.2% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to disrupt U.S. pharmaceutical companies by driving up costs for high-throughput screening equipment and drug formulation software imported from Switzerland and Germany, potentially delaying drug development timelines while increasing research and development expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of chronic diseases is expected to drive the growth of the formulation development outsourcing market in the future. Chronic diseases are long-lasting conditions that require ongoing medical care and can limit daily activities. Developing effective formulations and therapies for these conditions demands specialized expertise and resources. Formulation development outsourcing involves collaborating with external experts or specialized companies to handle the research, development, and optimization of drug formulations aimed at treating chronic diseases. For example, in November 2023, Eurostat, a government agency in Luxembourg, reported that over one-third (36.1%) of individuals in the EU faced a long-term chronic health condition in 2022. Therefore, the rising incidence of chronic diseases is fueling the growth of the formulation development outsourcing market.

The formulation development outsourcing market is also expected to witness growth due to the increasing demand for drugs. Drugs, substances used for medical treatment, disease prevention, symptom relief, or recreational purposes, are central to the healthcare industry. Formulation development outsourcing plays a crucial role in drug development, supporting activities such as the development of biopharmaceuticals and novel drug delivery systems, accelerating the drug development process, and providing a cost-effective solution for pharmaceutical companies. In April 2022, according to Fierce Healthcare, total drug expenditure in the United States witnessed a 7.7% growth in 2021, reaching $576.9 billion, and is projected to experience an estimated increase ranging from 4% to 6% in 2022. Therefore, the growing demand for drugs is a significant factor driving the growth of the formulation development outsourcing market.

Technological advancements represent a prominent trend gaining traction in the formulation development outsourcing market. Companies within this market are embracing cutting-edge technologies, such as artificial intelligence (AI) and machine learning (ML), to maintain their competitive positions. For example, in March 2023, Nvidia, a US-based software technology company, introduced BioNeMo Cloud, a novel component in their AI Foundations suite. This service grants researchers access to pre-trained AI models, facilitating customization with private data to expedite life sciences research, drug discovery, and protein engineering. Notably, industry leaders such as Amgen and numerous startups are leveraging this technology as a cloud service, accelerating drug development processes.

Major players in the formulation development outsourcing market are strategically focusing on enhancing various outsourcing capabilities, including method development. Method development capabilities denote an organization's or laboratory's expertise, skills, and resources to create, optimize, and validate analytical methods for analyzing various substances. For instance, in February 2022, Berkshire Sterile Manufacturing (BSM), a US-based sterile filling contract manufacturer, bolstered its clients' drug production capabilities by incorporating formulation, lyophilization, and method development expertise. BSM is expanding its services to cover first-in-human formulation development, providing materials for preclinical studies, and conducting research-level stability studies. Additionally, BSM is offering services for formulation optimization, process development, optimization, and scale-up studies, utilizing materials and equipment indicative of future Good Manufacturing Practice (GMP) manufacturing.

In August 2022, Catalent Inc., a US-based pharmaceutical company, completed the acquisition of Metrics Inc. for $475 million. This strategic move broadened, diversified, and enriched Catalent's portfolio by adding capabilities in integrated oral solid formulation development, manufacturing, and packaging. This expansion aims to assist customers in simplifying and accelerating their programs while enhancing their capacity to handle highly potent compounds. Metrics Inc. is a US-based global pharmaceutical formulation development organization specializing in novel oral dosage forms.

Major companies operating in the formulation development outsourcing market include Syngene International Ltd., Aizant Drug Research Solutions Private Limited., Catalent Inc., Intertek Group plc, Recipharm AB, SGS S.A., Lonza Group AG, Eurofins Scientific SE, Laboratory Corporation of America Holdings, Charles River Laboratories International Inc., Emergent Biosolutions Inc., IRISYS LLC, Piramal Pharma Limited., Biocon Limited., Dr Reddy's Laboratories Ltd., Quotient Sciences Ltd., Almac Group, Patheon, Evonik Industries AG, Metrics Contract Services, Aenova Group, Fareva Group, Vetter Pharma International GmbH, Aesica Pharmaceuticals, WuXi AppTec, Formosa Laboratories Inc., Aptuit LLC, ProPharma Group, Laurus Labs Limited

North America was the largest region in the global formulation development outsourcing market in 2024. The regions covered in the formulation development outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the formulation development outsourcing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The formulation development outsourcing market includes revenues earned by entities by providing services such as ingredient sourcing, stability studies, analytical testing, and regulatory support. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Formulation Development Outsourcing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on formulation development outsourcing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for formulation development outsourcing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The formulation development outsourcing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Service: Preformulation, Formulation Development
• 2) By Therapeutic Area: Oncology, Infectious Disease, Neurology, Hematology, Respiratory, Cardiovascular, Dermatology, Other Therapeutics
• 3) By Formulation: Oral, Injectable, Topical, Other Formulations
• 4) By End-User: Pharmaceutical Industries, Research And Academic Development
• Subsegments:
• 1) By Preformulation: Physicochemical Characterization; Stability Testing; Formulation Feasibility Studies; Analytical Method Development
• 2) By Formulation Development: Drug Formulation Development; Process Development; Scale-Up And Technology Transfer; Quality By Design (QbD) Development
• Companies Mentioned: Syngene International Ltd.; Aizant Drug Research Solutions Private Limited.; Catalent Inc.; Intertek Group plc; Recipharm AB; SGS S.A.; Lonza Group AG; Eurofins Scientific SE; Laboratory Corporation of America Holdings; Charles River Laboratories International Inc.; Emergent Biosolutions Inc.; IRISYS LLC; Piramal Pharma Limited.; Biocon Limited.; Dr Reddy's Laboratories Ltd.; Quotient Sciences Ltd.; Almac Group; Patheon; Evonik Industries AG; Metrics Contract Services; Aenova Group; Fareva Group; Vetter Pharma International GmbH; Aesica Pharmaceuticals; WuXi AppTec; Formosa Laboratories Inc.; Aptuit LLC; ProPharma Group; Laurus Labs Limited
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Formulation Development Outsourcing Market Characteristics

3. Formulation Development Outsourcing Market Trends And Strategies

4. Formulation Development Outsourcing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Formulation Development Outsourcing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Formulation Development Outsourcing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Formulation Development Outsourcing Market Growth Rate Analysis
• 5.4. Global Formulation Development Outsourcing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Formulation Development Outsourcing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Formulation Development Outsourcing Total Addressable Market (TAM)

6. Formulation Development Outsourcing Market Segmentation

• 6.1. Global Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Preformulation
• Formulation Development
• 6.2. Global Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Infectious Disease
• Neurology
• Hematology
• Respiratory
• Cardiovascular
• Dermatology
• Other Therapeutics
• 6.3. Global Formulation Development Outsourcing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Injectable
• Topical
• Other Formulations
• 6.4. Global Formulation Development Outsourcing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical Industries
• Research And Academic Development
• 6.5. Global Formulation Development Outsourcing Market, Sub-Segmentation Of Preformulation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Physicochemical Characterization
• Stability Testing
• Formulation Feasibility Studies
• Analytical Method Development
• 6.6. Global Formulation Development Outsourcing Market, Sub-Segmentation Of Formulation Development, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug Formulation Development
• Process Development
• Scale-Up And Technology Transfer
• Quality By Design (QbD) Development

7. Formulation Development Outsourcing Market Regional And Country Analysis

• 7.1. Global Formulation Development Outsourcing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Formulation Development Outsourcing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Formulation Development Outsourcing Market

• 8.1. Asia-Pacific Formulation Development Outsourcing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Formulation Development Outsourcing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Formulation Development Outsourcing Market

• 9.1. China Formulation Development Outsourcing Market Overview
• 9.2. China Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Formulation Development Outsourcing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Formulation Development Outsourcing Market

• 10.1. India Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Formulation Development Outsourcing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Formulation Development Outsourcing Market

• 11.1. Japan Formulation Development Outsourcing Market Overview
• 11.2. Japan Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Formulation Development Outsourcing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Formulation Development Outsourcing Market

• 12.1. Australia Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Formulation Development Outsourcing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Formulation Development Outsourcing Market

• 13.1. Indonesia Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Formulation Development Outsourcing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Formulation Development Outsourcing Market

• 14.1. South Korea Formulation Development Outsourcing Market Overview
• 14.2. South Korea Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Formulation Development Outsourcing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Formulation Development Outsourcing Market

• 15.1. Western Europe Formulation Development Outsourcing Market Overview
• 15.2. Western Europe Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Formulation Development Outsourcing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Formulation Development Outsourcing Market

• 16.1. UK Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Formulation Development Outsourcing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Formulation Development Outsourcing Market

• 17.1. Germany Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Formulation Development Outsourcing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Formulation Development Outsourcing Market

• 18.1. France Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Formulation Development Outsourcing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Formulation Development Outsourcing Market

• 19.1. Italy Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Formulation Development Outsourcing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Formulation Development Outsourcing Market

• 20.1. Spain Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Formulation Development Outsourcing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Formulation Development Outsourcing Market

• 21.1. Eastern Europe Formulation Development Outsourcing Market Overview
• 21.2. Eastern Europe Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Formulation Development Outsourcing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Formulation Development Outsourcing Market

• 22.1. Russia Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Formulation Development Outsourcing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Formulation Development Outsourcing Market

• 23.1. North America Formulation Development Outsourcing Market Overview
• 23.2. North America Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Formulation Development Outsourcing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Formulation Development Outsourcing Market

• 24.1. USA Formulation Development Outsourcing Market Overview
• 24.2. USA Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Formulation Development Outsourcing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Formulation Development Outsourcing Market

• 25.1. Canada Formulation Development Outsourcing Market Overview
• 25.2. Canada Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Formulation Development Outsourcing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Formulation Development Outsourcing Market

• 26.1. South America Formulation Development Outsourcing Market Overview
• 26.2. South America Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Formulation Development Outsourcing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Formulation Development Outsourcing Market

• 27.1. Brazil Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Formulation Development Outsourcing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Formulation Development Outsourcing Market

• 28.1. Middle East Formulation Development Outsourcing Market Overview
• 28.2. Middle East Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Formulation Development Outsourcing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Formulation Development Outsourcing Market

• 29.1. Africa Formulation Development Outsourcing Market Overview
• 29.2. Africa Formulation Development Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Formulation Development Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Formulation Development Outsourcing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Formulation Development Outsourcing Market Competitive Landscape And Company Profiles

• 30.1. Formulation Development Outsourcing Market Competitive Landscape
• 30.2. Formulation Development Outsourcing Market Company Profiles
  • 30.2.1. Syngene International Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Aizant Drug Research Solutions Private Limited. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Catalent Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Intertek Group plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Recipharm AB Overview, Products and Services, Strategy and Financial Analysis

31. Formulation Development Outsourcing Market Other Major And Innovative Companies

• 31.1. SGS S.A.
• 31.2. Lonza Group AG
• 31.3. Eurofins Scientific SE
• 31.4. Laboratory Corporation of America Holdings
• 31.5. Charles River Laboratories International Inc.
• 31.6. Emergent Biosolutions Inc.
• 31.7. IRISYS LLC
• 31.8. Piramal Pharma Limited.
• 31.9. Biocon Limited.
• 31.10. Dr Reddy's Laboratories Ltd.
• 31.11. Quotient Sciences Ltd.
• 31.12. Almac Group
• 31.13. Patheon
• 31.14. Evonik Industries AG
• 31.15. Metrics Contract Services

32. Global Formulation Development Outsourcing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Formulation Development Outsourcing Market

34. Recent Developments In The Formulation Development Outsourcing Market

35. Formulation Development Outsourcing Market High Potential Countries, Segments and Strategies

• 35.1 Formulation Development Outsourcing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Formulation Development Outsourcing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Formulation Development Outsourcing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer